Загрузка...
Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B
AIM: To investigate serum interleukin (IL)-38 level and its clinical role in predicting virological response (VR) to telbivudine (LdT) in patients with chronic hepatitis B (CHB). METHODS: The study participants were divided into two groups; one group consisted of 43 healthy controls (HCs) and the ot...
Сохранить в:
| Опубликовано в: : | World J Gastroenterol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4858634/ https://ncbi.nlm.nih.gov/pubmed/27182162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i18.4529 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|